Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2

Clinical trial NCT03758950 · COMPLETED

Trial details

NCT number: NCT03758950
Sponsor: Jeffrey Glassberg
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2018-11-29
Primary completion: 2023-05-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.